Investment
Features
FeesSafety
Academy
More
Pluang+

Trading resumes for GoldCoast Resource Corp. on Canadian markets after regulatory halt.

Market News
19 Oct 2026
Na
View Source
Neutral
Trading resumes for GoldCoast Resource Corp. on Canadian markets after regulatory halt.

Trading in all issues of GoldCoast Resource Corp. (symbol GCR) has resumed at 8:00 AM ET following a temporary halt imposed by the Canadian Investment Regulatory Organization (CIRO). Such halts are used to maintain fair and orderly markets. CIRO oversees trading activities and can suspend trading to ensure market integrity. Investors should contact the company directly for specific details about the halt or visit CIRO's website for general policies.

The Canadian Investment Regulatory Organization's trade resumption for GoldCoast Resource Corp. provides context for Basic Materials sector activity on Pluang. For readers following Basic Materials, here is Pluang's market snapshot as of Oct 20, 2026 03:42 WIB: Of 83 priced US stocks, 31 rose and 51 fell. MP Materials traded at USD 39.09 with a 1-day change of -2.69% and a Pluang order activity of 25% Sell / 75% Buy, while Aspen Aerogels Inc rose 2.50% to USD 5.32. Gold Fields Limited was priced at USD 36.69, down 2.42%, with 17% Sell / 83% Buy activity and a typical hold time of 50 days on Pluang.

More News

GE Aerospace Q3 earnings expected to show strong growth amid high investor expectations.

GE Aerospace Q3 earnings expected to show strong growth amid high investor expectations.

GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...

Company Fundamentals
Neutral
12 minutes ago
Silence Therapeutics jumps 125% after $1.3B acquisition deal with Merck KGaA

Silence Therapeutics jumps 125% after $1.3B acquisition deal with Merck KGaA

Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...

Market News
Bullish
12 minutes ago
Stocks tumble as Iambic Therapeutics and TCGX Acquisition lead losses amid IPO and merger news.

Stocks tumble as Iambic Therapeutics and TCGX Acquisition lead losses amid IPO and merger news.

On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...

Market News
Bearish
12 minutes ago
Equity Bancshares director buys shares amid strong Q3 earnings and dividend hike

Equity Bancshares director buys shares amid strong Q3 earnings and dividend hike

Equity Bancshares director Leon Borck increased his stake by purchasing 380 shares at $48.78 each, signaling confidence after the company reported strong Q3 results. The bank posted a net income of $26.8 million and core earnings of $1.40 per diluted...

Market News
Bullish
57 minutes ago
ICICI Bank Q2 FY2027 profit rises 20.1%, beating earnings and revenue estimates.

ICICI Bank Q2 FY2027 profit rises 20.1%, beating earnings and revenue estimates.

ICICI Bank reported a 20.1% year-over-year rise in standalone profit after tax to INR 148.43 billion for Q2 FY2027, surpassing earnings estimates with ADR earnings of $0.44 per share versus $0.41 expected. Revenue slightly exceeded forecasts at $3.52...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App